Clinical Trial Update: Bioavailability Study of BIA 5-453 [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 bioavailability study of BIA 5-453 conducted by Bial - Portela C S.A. The study focused on hypertension and con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hypertension

Drugs mentioned

• BIA 5-453

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Hypertension, Congestive Heart Failure | Phase 1 | Status: COMPLETED